Hepatotoxic Drugs Flashcards
Many drugs cause the asymptomatic elevation of hepatic enzymes, give an example of one of these drugs and hepatic enzymes:
Statins
- ALT
- AST
- GGT
- Alkaline phosphosphotase
Clinically significant liver injury is rare.
how does it present thouh?
Jaundice Abdominal pain Pruritis Impaired liver function resulting in deficient protein synthesis. Prolonged PT with hypoalbuminemia
What happens in phase 1 metabolic reactions
Drug is taken in and absorbed, broken down into metabolites which will either:
- Metabolite with modified activity
- Metabolite is inactivated
What happens in phase 2 of metabolic reactions?
Conjugation of drug metabolites
What are some consequences of drug metabolism?
- Product May become inactivated
- Product may become active
- Products May develop a new action
- Metabolites might become toxic
Name 5 mechanisms of injury in, drug induced liver injury:
- Covelant binding of drug to cellular proteins -> immune injury
- Inhibition of metabolic pathways
- Induction of apoptosis
- Blockage of cellular transport pumps
- Interference with mitochondrion function
What factors increase the risk of drug induced liver disease?
- Obesity
- Over the age of 18
- Pregnancy
- Concomitant with alcohol consumption
- Genetic polymorphism CYP2D6, CYP2C9
Name 3 drugs that pose as risk factors for DILI in old patients
Anti-TB drugs
Eruthromycine
Halothane
Flucloxacillin
Name 2 drugs that pose as risk factors for DILI in child patients:
Salicylate
Valproate
Name 2 drugs that pose as risk factors for DILI in obese patients:
Methotrexate
Halothane
Name a drug that pose as a risk factor for DILI in fasting/malnourished patients:
Acetaminophen
Name 3 drugs that pose as risk factors for DILI in female patients:
Doclofenac Erythromycin Isoniazid Flucloxacillin Halothane
Name 3 drugs that pose as risk factors for DILI in alcoholic patients:
Halothane
Methotrexate
Isoniazid
Acetominophen
Name 2 drugs that pose as risk factors for DILI in HIV patients:
Cotrimoxazole
Abacavir
Name 2 types of drugs that pose as risk factors for DILI in patients with HBV/HCV Co-infection :
Highly active ARV THERAPY
TB treatment